1. Divergent effects of sodium salicylate on glucose metabolism and reverse cholesterol transport in obesity. (September 2016) Authors: Kajani, S.; O'Reilly, M.; Guo, W.; McGillicuddy, F. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glucagon-like peptide 1 receptor agonist liraglutide impacts immune cell phenotypes in apolipoprotein e deficient mice during progression and regression of pre-established atherosclerosis. (August 2018) Authors: Bruen, R.; Curley, S.; Kajani, S.; O'reilly, M.; Hogan, A.; O'shea, D.; Mcgillicuddy, F.; Belton, O. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metabolically activated and classically activated pro-inflammatory M1 macrophages exhibit divergent effects on ABCA1 cholesterol efflux capacity. (August 2018) Authors: O'reilly, M.; Kajani, S.; Goodwin, M.; Hughes, K.; Roche, H.; Mcgillicuddy, F. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sodium salicylate modulates reverse cholesterol transport and HDL proteome within obesity. (August 2018) Authors: Kajani, S.; O'Reilly, M.; Guo, W.; Dillon, E.; McGillicuddy, F. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗